文献
J-GLOBAL ID:201802245837884270
整理番号:18A0998599
CCRKは癌免疫療法における新規シグナリングハブである【JST・京大機械翻訳】
CCRK is a novel signalling hub exploitable in cancer immunotherapy
著者 (8件):
Mok Myth T.
(School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China)
,
Zhou Jingying
(School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China)
,
Tang Wenshu
(School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China)
,
Zeng Xuezhen
(School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China)
,
Oliver Antony W.
(Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, UK)
,
Ward Simon E.
(Medicines Discovery Institute, Cardiff University, Main Building, Cardiff, Wales, CF10 3AT, UK)
,
Cheng Alfred S.
(School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China)
,
Cheng Alfred S.
(State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China)
資料名:
Pharmacology & Therapeutics
(Pharmacology & Therapeutics)
巻:
186
ページ:
138-151
発行年:
2018年
JST資料番号:
C0031D
ISSN:
0163-7258
CODEN:
PHTHDT
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)